Michael Woudenberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Woudenberg
Michael Woudenberg is recorded as COO at InMed Pharmaceuticals Inc. (INM). InMed Pharmaceuticals Inc. reported in an 8-K filed July 20, 2022 that Michael Woudenberg was appointed Chief Operating Officer. InMed Pharmaceuticals Inc. reported in an 8-K filed July 20, 2022 that Michael Woudenberg was appointed Chief Operating Officer, effective July 15, 2022.
“InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces Michael Woudenberg has been appointed Chief Operating Officer of the Company, overseeing all day-to-day operations.”
“On July 18, 2022, InMed Pharmaceuticals Inc. (the “Company”) issued a press release to announce that it has appointed Mr. Michael Woudenberg as the Company’s Chief Operating Officer effective July 15, 2022 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
InMed Pharmaceuticals Inc. (INM)
Source not stated
Current -
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at InMed Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Eric Adams CEO, Board Member
- N. Netta "Neeta" Jagpal CFO
- Netta Jagpal CFO
- Sarah Li Chief Accounting Officer
- Bryan Baldasare Board Member
- John Bathery Board Member
- Neil Klompas Board Member
- Nicole Lemerond Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.